72 related articles for article (PubMed ID: 22017238)
1. DNA-repair gene variants are associated with glioblastoma survival.
Wibom C; Sjöström S; Henriksson R; Brännström T; Broholm H; Rydén P; Johansen C; Collatz-Laier H; Hepworth S; McKinney PA; Bethke L; Houlston RS; Andersson U; Melin BS
Acta Oncol; 2012 Mar; 51(3):325-32. PubMed ID: 22017238
[TBL] [Abstract][Full Text] [Related]
2. A high frequency of MSH6 G268A polymorphism and survival association in glioblastoma.
Pei C; Chen H; Jia X; Yan L; Zou Y; Jiang C; Jin H; Kang C; Jiang T; Ren H
Int J Neurosci; 2013 Feb; 123(2):114-20. PubMed ID: 23057844
[TBL] [Abstract][Full Text] [Related]
3. Esophageal cancer risk is associated with polymorphisms of DNA repair genes MSH2 and WRN in Chinese population.
Li T; Suo Q; He D; Du W; Yang M; Fan X; Liu J
J Thorac Oncol; 2012 Feb; 7(2):448-52. PubMed ID: 22173703
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in the interleukin-4 receptor gene are associated with better survival in patients with glioblastoma.
Scheurer ME; Amirian E; Cao Y; Gilbert MR; Aldape KD; Kornguth DG; El-Zein R; Bondy ML
Clin Cancer Res; 2008 Oct; 14(20):6640-6. PubMed ID: 18927306
[TBL] [Abstract][Full Text] [Related]
5. DNA repair gene polymorphisms and risk of early onset colorectal cancer in Lynch syndrome.
Reeves SG; Meldrum C; Groombridge C; Spigelman A; Suchy J; Kurzawski G; Lubinski J; Scott RJ
Cancer Epidemiol; 2012 Apr; 36(2):183-9. PubMed ID: 21974800
[TBL] [Abstract][Full Text] [Related]
6. The expression of mismatch repair proteins MLH1, MSH2 and MSH6 correlates with the Ki67 proliferation index and survival in patients with recurrent glioblastoma.
Stark AM; Doukas A; Hugo HH; Mehdorn HM
Neurol Res; 2010 Oct; 32(8):816-20. PubMed ID: 20223108
[TBL] [Abstract][Full Text] [Related]
7. Germline polymorphisms in myeloid-associated genes are not associated with survival in glioma patients.
Jacobs DI; Liu Y; Gabrusiewicz K; Tsavachidis S; Armstrong GN; Zhou R; Wei J; Ivan C; Calin G; Molinaro AM; Rice T; Bracci PM; Hansen HM; Wiencke JK; Wrensch MR; Heimberger AB; Bondy ML
J Neurooncol; 2018 Jan; 136(1):33-39. PubMed ID: 28965162
[TBL] [Abstract][Full Text] [Related]
8. Analysis of DNA repair gene polymorphisms in glioblastoma.
Rodriguez-Hernandez I; Perdomo S; Santos-Briz A; Garcia JL; Gomez-Moreta JA; Cruz JJ; Gonzalez-Sarmiento R
Gene; 2014 Feb; 536(1):79-83. PubMed ID: 24325908
[TBL] [Abstract][Full Text] [Related]
9. Promoter methylation and expression of MGMT and the DNA mismatch repair genes MLH1, MSH2, MSH6 and PMS2 in paired primary and recurrent glioblastomas.
Felsberg J; Thon N; Eigenbrod S; Hentschel B; Sabel MC; Westphal M; Schackert G; Kreth FW; Pietsch T; Löffler M; Weller M; Reifenberger G; Tonn JC;
Int J Cancer; 2011 Aug; 129(3):659-70. PubMed ID: 21425258
[TBL] [Abstract][Full Text] [Related]
10. Expression of DNA mismatch repair proteins MLH1, MSH2, and MSH6 in recurrent glioblastoma.
Stark AM; Doukas A; Hugo HH; Hedderich J; Hattermann K; Maximilian Mehdorn H; Held-Feindt J
Neurol Res; 2015 Feb; 37(2):95-105. PubMed ID: 24995467
[TBL] [Abstract][Full Text] [Related]
11. Association of the CC genotype of the regulatory BCL2 promoter polymorphism (-938C>A) with better 2-year survival in patients with glioblastoma multiforme.
El Hindy N; Bachmann HS; Lambertz N; Adamzik M; Nückel H; Worm K; Zhu Y; Sure U; Siffert W; Sandalcioglu IE
J Neurosurg; 2011 Jun; 114(6):1631-9. PubMed ID: 21250804
[TBL] [Abstract][Full Text] [Related]
12. Allelic variants of XRCC1 and XRCC3 repair genes and susceptibility of oral cancer in Brazilian patients.
Dos Reis MB; Losi-Guembarovski R; de Souza Fonseca Ribeiro EM; Cavalli IJ; Morita MC; Ramos GH; de Oliveira BV; Mizuno LT; Rogatto SR; de Syllos Cólus IM
J Oral Pathol Med; 2013 Feb; 42(2):180-5. PubMed ID: 22775506
[TBL] [Abstract][Full Text] [Related]
13. SSBP2 variants are associated with survival in glioblastoma patients.
Xiao Y; Decker PA; Rice T; McCoy LS; Smirnov I; Patoka JS; Hansen HM; Wiemels JL; Tihan T; Prados MD; Chang SM; Berger MS; Kosel ML; Fridley BL; Lachance DH; O'Neill BP; Buckner JC; Thompson RC; Nabors LB; Olson JJ; Brem S; Madden MH; Browning JE; Wiencke JK; Egan KM; Jenkins RB; Wrensch MR
Clin Cancer Res; 2012 Jun; 18(11):3154-62. PubMed ID: 22472174
[TBL] [Abstract][Full Text] [Related]
14. Molecular predictors of progression-free and overall survival in patients with newly diagnosed glioblastoma: a prospective translational study of the German Glioma Network.
Weller M; Felsberg J; Hartmann C; Berger H; Steinbach JP; Schramm J; Westphal M; Schackert G; Simon M; Tonn JC; Heese O; Krex D; Nikkhah G; Pietsch T; Wiestler O; Reifenberger G; von Deimling A; Loeffler M
J Clin Oncol; 2009 Dec; 27(34):5743-50. PubMed ID: 19805672
[TBL] [Abstract][Full Text] [Related]
15. Variant of the CHEK2 gene as a prognostic marker in glioblastoma multiforme.
Simon M; Ludwig M; Fimmers R; Mahlberg R; Müller-Erkwoh A; Köster G; Schramm J
Neurosurgery; 2006 Nov; 59(5):1078-85; discussion 1085. PubMed ID: 17016233
[TBL] [Abstract][Full Text] [Related]
16. The role of a single nucleotide polymorphism of MDM2 in glioblastoma multiforme.
Khatri RG; Navaratne K; Weil RJ
J Neurosurg; 2008 Nov; 109(5):842-8. PubMed ID: 18976073
[TBL] [Abstract][Full Text] [Related]
17. Xeroderma pigmentosum complementation group C single-nucleotide polymorphisms in the nucleotide excision repair pathway correlate with prolonged progression-free survival in advanced ovarian cancer.
Fleming ND; Agadjanian H; Nassanian H; Miller CW; Orsulic S; Karlan BY; Walsh CS
Cancer; 2012 Feb; 118(3):689-97. PubMed ID: 21751198
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms of LIG4, BTBD2, HMGA2, and RTEL1 genes involved in the double-strand break repair pathway predict glioblastoma survival.
Liu Y; Shete S; Etzel CJ; Scheurer M; Alexiou G; Armstrong G; Tsavachidis S; Liang FW; Gilbert M; Aldape K; Armstrong T; Houlston R; Hosking F; Robertson L; Xiao Y; Wiencke J; Wrensch M; Andersson U; Melin BS; Bondy M
J Clin Oncol; 2010 May; 28(14):2467-74. PubMed ID: 20368557
[TBL] [Abstract][Full Text] [Related]
19. Association between genetic polymorphisms in the XRCC1, XRCC3, XPD, GSTM1, GSTT1, MSH2, MLH1, MSH3, and MGMT genes and radiosensitivity in breast cancer patients.
Mangoni M; Bisanzi S; Carozzi F; Sani C; Biti G; Livi L; Barletta E; Costantini AS; Gorini G
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):52-8. PubMed ID: 20708344
[TBL] [Abstract][Full Text] [Related]
20. Genetic variation in the DNA repair genes is predictive of outcome in lung cancer.
Matakidou A; el Galta R; Webb EL; Rudd MF; Bridle H; ; Eisen T; Houlston RS
Hum Mol Genet; 2007 Oct; 16(19):2333-40. PubMed ID: 17855454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
